BioSpace News Archive

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in four upcoming virtual conferences.

Oligomerix, Inc., a privately held company pioneering the development of small molecule therapeutics targeting tau for Alzheimer’s disease (AD) and related neurodegenerative disorders, today announced that the company was awarded a $3.19 million grant from the National Institute on Aging (NIA) at National Institutes of Health (NIH)

Kronos Bio, Inc., a private clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes by targeting dysregulated transcription, today announced that the company has appointed Elena Ridloff, CFA, to its Board of Directors, where she will serve as Chair of the Audit Committee

Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has released version 10.0 of its flagship machine learning modeling platform, ADMET Predictor®

Tridiuum, the nation’s premier provider of digital behavioral health solutions, today announced it has been named Healthcare Innovator of the Year by the Philadelphia Alliance for Capital and Technologies (PACT). Tridiuum received the prestigious honor during PACT’s 27th Annual Enterprise Awards ceremony, held virtually on Sept. 9, 2020.

Sensentia, a leading-edge healthtech company focused on artificial intelligence, is exhibiting at the AHIP National Conference on Medicare, Medicaid and Dual Eligibles hosted virtually from September 14th to 17th.

Aldevron, a leading manufacturer of plasmid DNA, proteins and mRNA, today announced the sale of its Germany based antibody discovery business

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Arcutis management will participate in a fireside chat presentation during the Cantor Fitzgerald Global Healthcare Conference 2020 taking place Sept. 15-17, 2020. Details for t

ControlRad, Inc., a privately held medical technology company focused on dramatically reducing unnecessary radiation exposure during fluoroscopically guided procedures, today announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for ControlRad Trace use on OEC 9900 Mobile C-arms

Advocates from kidney organizations around the country will converge virtually on September 16th for meetings with their Congressional delegations to inspire action for kidney disease at the 7th Annual Kidney Patient Summit. Originally scheduled as an in-person Summit to be held in the nation’s capital last March,